Greetings on yet another issue of The Prescription!
Strengthening healthcare delivery system will not only improve accessibility but will assure universal health coverage of high quality and safety. Read about this in PSM India capsules as the 1st regional quality conclave on Universal Health Coverage through Ayushman Bharat was held in Varanasi. Another interesting read in this section is how a new technique for precisely targeting molecules within cells is paving the way for safer medicines that are free of side effects.
Important drug laws and government body policies are getting implemented such as drugs irrespective of branded or generic are required to comply with the same standards, uniform implementation of new labeling norms, review of production and distribution of oxytocin, working on Blockchain technology for drug industry and drug controllers to get power to issue NOCs for Drug meant for export.
Indian Pharma companies are constantly on the run be it either with increasing their market share in the US generic market, gearing up with copycat versions of Viagra, dealing with the Oxytoxin ban or developing new medical devices that are set to change the face of healthcare in India. Read about it all in our Pharma Injections while updating yourselves on medicines that have been recently approved, banned and proven dangerous to health in our drug dopes section.
Do not hesitate to mail your comments on this edition to help us further improve. We appreciate your support and trust in us and are happy to have you as our loyal reader.
Feedback is what keeps us going. Should you have any query or question, please feel free to get in touch with us. Write to me on pooja@jagograhakjago.com
Stay Healthy. Stay Protected.
Pooja Khaitan
Editor-in-Chief,
The Prescription
“We have to do something but my own hypotheses is that the Ayushman Bharat scheme itself is going to encourage private sector to come up in poor areas. Why we don't have good services in poor areas, one reason is that there is no paying capacity. If private sector is motivated by profit then why would they open hospitals where people cannot pay, but now they can, now the poor don't pay themselves but can make the government pay.”
Indu Bhushan,
CEO, Ayushman Bharat
1st Regional Quality Conclave on Universal Health Coverage through Ayushman Bharat : Assisting Implementation
9th August, Varanasi: First Quality Conclave on Universal Health Coverage through Ayushman Bharat Assisting Implementation at BHU Varanasi on 9th August 2018 took off with a galaxy of experts in the healthcare delivery system in India and more than 600 participants representing all the stakeholders including active Patients’ Groups and Consumer Organisations. The event was inaugurated by Dr. Rakesh Bhatnagar Vice Chancellor of Banaras Hindu University and the Key Note Address was given by Dr V. K. Shukla, Director of Institute of Medical Sciences and Guest of Honour was Dr. N K Ganguly, former Director of ICMR. Welcome Address was given by Dr Ravi Singh Secretary General of QCI and Vote of Thanks by Prof Bejon Misra, GB Member QCI and founder director PSM India Initiative.
A new technique for precisely targeting molecules within cells is paving the way for safer medicines that are free of side effects. Researcher J. Julius Zhu, PhD, of the University of Virginia School of Medicine, and his colleagues have developed a way to manipulate molecules from compartment to compartment within individual cells. Amazingly, the same molecules do different things depending on their location, the researchers determined. By manipulating the molecules, scientists can determine exactly which locations to target, while avoiding locations that would cause harmful side effects.
US FDA Seals Loophole That Allowed Some Drugmakers To Avoid Pediatric Clinical Trials
Maryland, 27 July 2018: The Food and Drug Administration moved Friday to close a loophole that had inadvertently excused some drugmakers from having to conduct clinical trials in children for drugs to treat diseases that commonly affect adults.
Bacterial Superbugs Have Become Up To 10 Times More Tolerant To Alcohol-Based Hand Sanitizers
Canberra, 3 Aug 2018: Many hospitals around the world have installed hand sanitizers for staff, visitors, and patients to use. However, the bacteria was quick to react. A new study found that superbugs found in Australian hospitals have become up to ten times more tolerant to alcohol exposure, the key ingredient in hand sanitizers.
Enzyme Could Make 'Smart' Cancer Drugs A Reality
Texas, 20 July 2018: A type of enzyme called matrix metalloproteinase could be key to the development of “smart” cancer drugs, according to new research.
Anti-Depressants Linked With Blood Clot Condition: Study
London, 25 July 2018: Increased use of anti-depressants -- drugs used to treat major depressive disorders -- may be associated with developing a high risk of fatal blood clot condition, says a study.
Counterfeit Fentanyl Pills And Powder Being Seized In Ever Larger Amounts In Arizona
August 9, 2018: Reports coming in from Arizona paint a worrisome picture in the state’s battle against counterfeit fentanyl pills. As the Daily Miner reported, fake Xanax pills made with fentanyl have been reported in Kingman, a town of approximately 30,000.
New York Residents Charged After Being Found With Over 12 Kilos Of Counterfeit Xanax Pills
August 9, 2018: In June 2018, the U.S. Department of Justice (DOJ) announced the results of a year-long national operation that used undercover agents to target vendors selling illicit drugs on the internet. The investigation identified 65 targets and resulted in indictments against 35 vendors.
Frequently Asked Questions
Questions about Antibiotic Resistance
Q: What is antibiotic resistance?
Ans: Antibiotic resistance occurs when bacteria develop the ability to defeat the drugs designed to kill them. When bacteria become resistant, antibiotics cannot fight them, and the bacteria multiply. Read More>>>
Are you Ready for EU FMD Urgency, Consistency and Planning are Key - Vikash Pushpraj
Article contributed by Tea Rajic, Marketing Manager, rfxcel, San Ramon CA
With the deadline looming for enactment of EU FMD and US DSCSA, Vikash Pushpraj, SVP, rfxcel, explains how achieving compliance is about much more than technology. Companies not yet set up for serialisation will need to adopt best practices and leverage the know-how of implementation experts in their methodology to go-live on time.
Ayush Healthy Life organization says:“The Prescription has empowered us for fight against fake medicines.”
Dr. Gupta tweets: “PSM India/ PSAIIF is worthy of appreciation for its endeavour against spurious drugs.”
F-9, 2nd floor, Kailash Colony, New Delhi -110048
jagograhakjago.com; www.jagograhakjago.com;
Disclaimer : Our newsletter endeavors to compile patient safety information from various sources . PSM India may not be held responsible for any article published in The Prescription.